top of page

Gruppo 1MANICOMIOTRAIPALI

Pubblico·4 membri

  • The global interleukin inhibitors market size was valued at USD 32.64 billion in 2024 and is expected to reach USD 85.51 billion by 2032, growing at a CAGR of 13.4% during the forecast period.

  • This growth is driven by factors such as the rising prevalence of autoimmune and chronic inflammatory diseases, increasing awareness and adoption of biologic therapies, and continuous advancements in targeted immunotherapy.


4 visualizzazioni

1MANICOMIOTRAIPALI

©2023 by 1MANICOMIOTRAIPALI. Creato con Wix.com

bottom of page